PPARs in fetal and early postnatal development

Advances in Developmental Biology

Volumn 16, Issue , 2006, Pages 33-64

  Rotman, Nicolas ^a   Michalik, Liliane ^a   Desvergne, Béatrice ^a   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750916580     PISSN: 15743349     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1574-3349(06)16002-0     Document Type: Review

References (99)

1. Adams M., Reginato M.J., Shao D., Lazar M.A., and Chatterjee V.K. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272 (1997) 5128-5132
2. Ali A.A., Weinstein R.S., Stewart S.A., Parfitt A.M., Manolagas S.C., and Jilka R.L. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146 (2005) 1226-1235
3. Altiok S., Xu M., and Spiegelman B.M. PPARgamma induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11 (1997) 1987-1998
4. Amri E.Z., Bonino F., Ailhaud G., Abumrad N.A., and Grimaldi P.A. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J. Biol. Chem. 270 (1995) 2367-2371
5. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., and Evans R.M. PPARgamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 4 (1999) 585-595
6. Barak Y., Liao D., He W., Ong E.S., Nelson M.C., Olefsky J.M., Boland R., and Evans R.M. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA 99 (2002) 303-308
7. Bastie C., Luquet S., Holst D., Jehl-Pietri C., and Grimaldi P.A. Alterations of peroxisome proliferator-activated receptor delta activity affect fatty acid-controlled adipose differentiation. J. Biol. Chem. 275 (2000) 38768-38773
8. Bennett C.N., Ross S.E., Longo K.A., Bajnok L., Hemati N., Johnson K.W., Harrison S.D., and Macdougald O.A. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277 (2002) 30998-31004
9. Berry E.B., Keelan J.A., Helliwell R.J., Gilmour R.S., and Mitchell M.D. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: Differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa. B. Mol. Pharmacol. 68 (2005) 169-178
10. Bildirici I., Roh C.R., Schaiff W.T., Lewkowski B.M., Nelson D.M., and Sadovsky Y. The lipid droplet-associated protein adipophilin is expressed in human trophoblasts and is regulated by peroxisomal proliferator-activated receptor-gamma/retinoid X receptor. J. Clin. Endocrinol. Metab. 88 (2003) 6056-6062
11. Braissant O., and Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 139 (1998) 2748-2754
12. Braissant O., Foufelle F., Scotto C., Dauca M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137 (1996) 354-366
13. Cimini A., Benedetti E., Cristiano L., Sebastiani P., D'amico M.A., D'angelo B., and Di Loreto S. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience 130 (2005) 325-337
14. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
15. Di-Poi N., Tan N.S., Michalik L., Wahli W., and Desvergne B. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol. Cell 10 (2002) 721-733
16. Di-Poi N., Desvergne B., Michalik L., and Wahli W. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins. J. Biol. Chem. 280 (2005) 38700-38710
17. Di-Poi N., Ng C.Y., Tan N.S., Yang Z., Hemmings B.A., Desvergne B., Michalik L., and Wahli W. Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development. Mol. Cell. Biol. 25 (2005) 1696-1712
18. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., and Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68 (1992) 879-887
19. Drori S., Girnun G.D., Tou L., Szwaya J.D., Mueller E., Xia K., Shivdasani R.A., and Spiegelman B.M. Hic-5 regulates an epithelial program mediated by PPARgamma. Genes Dev. 19 (2005) 362-375
20. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Saladin R., Najib J., Laville M., Fruchart J.C., Deeb S., Vidal-Puig A., Flier J., et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 272 (1997) 18779-18789
21. Fajas L., Landsberg R.L., Huss-Garcia Y., Sardet C., Lees J.A., and Auwerx J. E2Fs regulate adipocyte differentiation. Dev. Cell 3 (2002) 39-49
22. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 (1995) 803-812
23. Fournier T., Pavan L., Tarrade A., Schoonjans K., Auwerx J., Rochette-Egly C., and Evain-Brion D. The role of PPAR-gamma/RXR-alpha heterodimers in the regulation of human trophoblast invasion. Ann. NY Acad. Sci. 973 (2002) 26-30
24. Fu M., Rao M., Bouras T., Wang C., Wu K., Zhang X., Li Z., Yao T.P., and Pestell R.G. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J. Biol. Chem. 280 (2005) 16934-16941
25. Granneman J., Skoff R., and Yang X. Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes. J. Neurosci. Res. 51 (1998) 563-573
26. Gregoire F.M., Smas C.M., and Sul H.S. Understanding adipocyte differentiation. Physiol. Rev. 78 (1998) 783-809
27. Gurnell M., Wentworth J.M., Agostini M., Adams M., Collingwood T.N., Provenzano C., Browne P.O., Rajanayagam O., Burris T.P., Schwabe J.W., Lazar M.A., and Chatterjee V.K. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J. Biol. Chem. 275 (2000) 5754-5759
28. Hanley K., Jiang Y., Crumrine D., Bass N.M., Appel R., Elias P.M., Williams M.L., and Feingold K.R. Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J. Clin. Invest. 100 (1997) 705-712
29. Hanley K., Komuves L.G., Bass N.M., He S.S., Jiang Y., Crumrine D., Appel R., Friedman M., Bettencourt J., Min K., Elias P.M., Williams M.L., et al. Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators. J. Invest. Dermatol. 113 (1999) 788-795
30. Hansen J.B., Zhang H., Rasmussen T.H., Petersen R.K., Flindt E.N., and Kristiansen K. Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J. Biol. Chem. 276 (2001) 3175-3182
31. Haunerland N.H., and Spener F. Fatty acid-binding proteins-insights from genetic manipulations. Prog. Lipid Res. 43 (2004) 328-349
32. Hirning-Folz U., Wilda M., Rippe V., Bullerdiek J., and Hameister H. The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer 23 (1998) 350-357
33. Hong J.H., Hwang E.S., Mcmanus M.T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B.M., Sharp P.A., Hopkins N., and Yaffe M.B. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309 (2005) 1074-1078
34. Hu E., Tontonoz P., and Spiegelman B.M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc. Natl. Acad. Sci. USA 92 (1995) 9856-9860
35. Hunt C.R., Ro J.H., Dobson D.E., Min H.Y., and Spiegelman B.M. Adipocyte P2 gene: Developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc. Natl. Acad. Sci. USA 83 (1986) 3786-3790
36. Imai T., Takakuwa R., Marchand S., Dentz E., Bornert J.M., Messaddeq N., Wendling O., Mark M., Desvergne B., Wahli W., Chambon P., and Metzger D. Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc. Natl. Acad. Sci. USA 101 (2004) 4543-4547
37. Issemann I., and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 (1990) 645-650
38. Juge-Aubry C.E., Gorla-Bajszczak A., Pernin A., Lemberger T., Wahli W., Burger A.G., and Meier C.A. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat. J. Biol. Chem. 270 (1995) 18117-18122
39. Juge-Aubry C., Pernin A., Favez T., Burger A.G., Wahli W., Meier C.A., and Desvergne B. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem. 272 (1997) 25252-25259
40. Kamei T., Jones S.R., Chapman B.M., Kl M.C., Dai G., and Soares M.J. The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells. Mol. Endocrinol. 16 (2002) 1469-1481
41. Kang S., Bajnok L., Longo K.A., Petersen R.K., Hansen J.B., Kristiansen K., and Macdougald O.A. Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha. Mol. Cell. Biol. 25 (2005) 1272-1282
42. Karam S.M. Lineage commitment and maturation of epithelial cells in the gut. Front. Biosci. 4 (1999) D286-D298
43. Keller J.M., Collet P., Bianchi A., Huin C., Bouillaud-Kremarik P., Becuwe P., Schohn H., Domenjoud L., and Dauca M. Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease. Int. J. Dev. Biol. 44 (2000) 429-442
44. Kersten S., Desvergne B., and Wahli W. Roles of PPARs in health and disease. Nature 405 (2000) 421-424
45. Kim D.J., Bility M.T., Billin A.N., Willson T.M., Gonzalez F.J., and Peters J.M. PPARbeta/delta selectively induces differentiation and inhibits cell proliferation. Cell Death Differ. 13 (2006) 53-60
46. Kim M.J., Deplewski D., Ciletti N., Michel S., Reichert U., and Rosenfield R.L. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development. Mol. Genet. Metab. 74 (2001) 362-369
47. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., Umesono K., and Evans R.M. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91 (1994) 7355-7359
48. Koeffler H.P. Peroxisome proliferator-activated receptor gamma and cancers. Clin. Cancer Res. 9 (2003) 1-9
49. Komuves L.G., Hanley K., Jiang Y., Elias P.M., Williams M.L., and Feingold K.R. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J. Invest. Dermatol. 111 (1998) 429-433
50. Kortum R.L., Costanzo D.L., Haferbier J., Schreiner S.J., Razidlo G.L., Wu M.H., Volle D.J., Mori T., Sakaue H., Chaika N.V., Chaika O.V., and Lewis R.E. The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis. Mol. Cell. Biol. 25 (2005) 7592-7604
51. Kraut N., Snider L., Chen C.M., Tapscott S.J., and Groudine M. Requirement of the mouse I-mfa gene for placental development and skeletal patterning. EMBO J. 17 (1998) 6276-6288
52. Lampen A., Grimaldi P.A., and Nau H. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation. Mol. Pharmacol. 68 (2005) 193-203
53. Lathion C., Michalik L., and Wahli W. Physiological ligands of PPARs in inflammation and lipid homeostasis. Future Lipidol. 1 (2006) 191-201
54. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., and Gonzalez F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15 (1995) 3012-3022
55. Lefebvre M., Paulweber B., Fajas L., Woods J., Mccrary C., Colombel J.F., Najib J., Fruchart J.C., Datz C., Vidal H., Desreumaux P., and Auwerx J. Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J. Endocrinol. 162 (1999) 331-340
56. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270 (1995) 12953-12956
57. Matsusue K., Peters J.M., and Gonzalez F.J. PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation. FASEB J. 18 (2004) 1477-1479
58. Michalik L., Desvergne B., Tan N.S., Basu-Modak S., Escher P., Rieusset J., Peters J.M., Kaya G., Gonzalez F.J., Zakany J., Metzger D., Chambon P., et al. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J. Cell Biol. 154 (2001) 799-814
59. Michalik L., Desvergne B., and Wahli W. Peroxisome-proliferator-activated receptors and cancers: Complex stories. Nat. Rev. Cancer 4 (2004) 61-70
60. Moldes M., Zuo Y., Morrison R.F., Silva D., Park B.H., Liu J., and Farmer S.R. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem. J. 376 (2003) 607-613
61. Morrison R.F., and Farmer S.R. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J. Biol. Chem. 274 (1999) 17088-17097
62. Nadra K., Anghel S.I., Joye E., Tan N.S., Basu-Modak S., Trono D., Wahli W., and Desvergne B. Differentiation of trophoblast giant cells and their metabolic functions are dependent on PPARβ/δ. Mol. Cell. Biol. 26 (2006) 3266-3281
63. Nakayama H., Liu Y., Stifani S., and Cross J.C. Developmental restriction of Mash-2 expression in trophoblast correlates with potential activation of the notch-2 pathway. Dev. Genet. 21 (1997) 21-30
64. Oberfield J.L., Collins J.L., Holmes C.P., Goreham D.M., Cooper J.P., Cobb J.E., Lenhard J.M., Hull-Ryde E.A., Mohr C.P., Blanchard S.G., Parks D.J., Moore L.B., et al. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Proc. Natl. Acad. Sci. USA 96 (1999) 6102-6106
65. Park B.H., Qiang L., and Farmer S.R. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol. Cell. Biol. 24 (2004) 8671-8680
66. Peters J.M., Lee S.S., Li W., Ward J.M., Gavrilova O., Everett C., Reitman M.L., Hudson L.D., and Gonzalez F.J. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol. Cell. Biol. 20 (2000) 5119-5128
67. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
68. Prusty D., Park B.H., Davis K.E., and Farmer S.R. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 277 (2002) 46226-46232
69. Rim J.S., Xue B., Gawronska-Kozak B., and Kozak L.P. Sequestration of thermogenic transcription factors in the cytoplasm during development of brown adipose tissue. J. Biol. Chem. 279 (2004) 25916-25926
70. Rosen E.D., and Spiegelman B.M. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16 (2000) 145-171
71. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., Spiegelman B.M., and Mortensen R.M. PPARgamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4 (1999) 611-617
72. Rosen E.D., Hsu C.H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., and Spiegelman B.M. C/EBPalpha induces adipogenesis through PPARgamma: A unified pathway. Genes Dev. 16 (2002) 22-26
73. Rosenfield R.L., Kentsis A., Deplewski D., and Ciletti N. Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. J. Invest. Dermatol. 112 (1999) 226-232
74. Ross S.E., Erickson R.L., Hemati N., and Macdougald O.A. Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase. Mol. Cell. Biol. 19 (1999) 8433-8441
75. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., and Macdougald O.A. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
76. Rossant J., and Cross J.C. Placental development: Lessons from mouse mutants. Nat. Rev. Genet. 2 (2001) 538-548
77. Ryves W.J., and Harwood A.J. The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle. Prog. Cell Cycle Res. 5 (2003) 489-495
78. Saluja I., Granneman J.G., and Skoff R.P. PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture. Glia 33 (2001) 191-204
79. Sandouk T., Reda D., and Hofmann C. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am. J. Physiol. 264 (1993) C1600-C1608
80. Schaiff W.T., Carlson M.G., Smith S.D., Levy R., Nelson D.M., and Sadovsky Y. Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. J. Clin. Endocrinol. Metab. 85 (2000) 3874-3881
81. Schaiff W.T., Bildirici I., Cheong M., Chern P.L., Nelson D.M., and Sadovsky Y. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J. Clin. Endocrinol. Metab. 90 (2005) 4267-4275
82. Schmuth M., Haqq C.M., Cairns W.J., Holder J.C., Dorsam S., Chang S., Lau P., Fowler A.J., Chuang G., Moser A.H., Brown B.E., Mao-Qiang M., et al. Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J. Invest. Dermatol. 122 (2004) 971-983
83. Shalom-Barak T., Nicholas J.M., Wang Y., Zhang X., Ong E.S., Young T.H., Gendler S.J., Evans R.M., and Barak Y. Peroxisome proliferator-activated receptor gamma controls Muc1 transcription in trophoblasts. Mol. Cell. Biol. 24 (2004) 10661-10669
84. Shao D., and Lazar M.A. Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation. J. Biol. Chem. 272 (1997) 21473-21478
85. Tan N.S., Michalik L., Noy N., Yasmin R., Pacot C., Heim M., Fluhmann B., Desvergne B., and Wahli W. Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev. 15 (2001) 3263-3277
86. Tan N.S., Shaw N.S., Vinckenbosch N., Liu P., Yasmin R., Desvergne B., Wahli W., and Noy N. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol. Cell. Biol. 22 (2002) 5114-5127
87. Tang Q.Q., Gronborg M., Huang H., Kim J.W., Otto T.C., Pandey A., and Lane M.D. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc. Natl. Acad. Sci. USA 102 (2005) 9766-9771
88. Tang X., Guilherme A., Chakladar A., Powelka A.M., Konda S., Virbasius J.V., Nicoloro S.M., Straubhaar J., and Czech M.P. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPAR{gamma}, adipogenesis, and insulin-responsive hexose transport. Proc. Natl. Acad. Sci. USA 103 (2006) 2087-2092
89. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 (1994) 1147-1156
90. Van Den Brink G.R., Bleuming S.A., Hardwick J.C., Schepman B.L., Offerhaus G.J., Keller J.J., Nielsen C., Gaffield W., Van Deventer S.J., Roberts D.J., and Peppelenbosch M.P. Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat. Genet. 36 (2004) 277-282
91. Varnat F., Heggeler B.B., Grisel P., Boucart N., Corthesy-Theulaz I., Wahli W., and Desvergne B. PPARβ/δ regulates Paneth cell differentiation via controlling the hedgehog signaling pathway. Gastroenterology 131 (2006) 538-553
92. Vernochet C., Milstone D.S., Iehle C., Belmonte N., Phillips B., Wdziekonski B., Villageois P., Amri E.Z., O'donnell P.E., Mortensen R.M., Ailhaud G., and Dani C. PPARgamma-dependent and PPARgamma-independent effects on the development of adipose cells from embryonic stem cells. FEBS Lett. 510 (2002) 94-98
93. Waite L.L., Person E.C., Zhou Y., Lim K.H., Scanlan T.S., and Taylor R.N. Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J. Clin. Endocrinol. Metab. 85 (2000) 3808-3814
94. Wang L., Shao Y.Y., and Ballock R.T. Peroxisome proliferator activated receptor-gamma (PPARgamma) represses thyroid hormone signaling in growth plate chondrocytes. Bone 37 (2005) 305-312
95. Wang L.C., Nassir F., Liu Z.Y., Ling L., Kuo F., Crowell T., Olson D., Davidson N.O., and Burkly L.C. Disruption of hedgehog signaling reveals a novel role in intestinal morphogenesis and intestinal-specific lipid metabolism in mice. Gastroenterology 122 (2002) 469-482
96. Werling U., Siehler S., Litfin M., Nau H., and Gottlicher M. Induction of differentiation in F9 cells and activation of peroxisome proliferator-activated receptor delta by valproic acid and its teratogenic derivatives. Mol. Pharmacol. 59 (2001) 1269-1276
97. Woods J.W., Tanen M., Figueroa D.J., Biswas C., Zycband E., Moller D.E., Austin C.P., and Berger J.P. Localization of PPARdelta in murine central nervous system: Expression in oligodendrocytes and neurons. Brain Res. 975 (2003) 10-21
98. Yang Q., Yamada A., Kimura S., Peters J.M., and Gonzalez F.J. Alterations in skin and stratified epithelia by constitutively activated PPARalpha. J. Invest. Dermatol. 126 (2006) 374-385
99. Zhang J., Fu M., Cui T., Xiong C., Xu K., Zhong W., Xiao Y., Floyd D., Liang J., Li E., Song Q., and Chen Y.E. Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity. Proc. Natl. Acad. Sci. USA 101 (2004) 10703-10708